Nab-Paclitaxel in Combination With Carboplatin as First-line Therapy in Patients With NSCLC

Clinical trial NCT02799862 · COMPLETED

Trial details

NCT number: NCT02799862
Sponsor: iOMEDICO AG
Status: COMPLETED
Study type: OBSERVATIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2016-08-29
Primary completion: 2019-12-07
Enrollment: 408

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.